Document Detail


4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
MedLine Citation:
PMID:  19285976     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyaluronan accumulation on cancer cells and their surrounding stroma predicts an unfavourable disease outcome, suggesting that hyaluronan enhances tumor growth and spreading. 4-Methylumbelliferone (4-MU) inhibits hyaluronan synthesis and retards cancer spreading in experimental animals through mechanisms not fully understood. These mechanisms were studied in A2058 melanoma cells, MCF-7 and MDA-MB-361 breast, SKOV-3 ovarian and UT-SCC118 squamous carcinoma cells by analysing hyaluronan synthesis, UDP-glucuronic acid (UDP-GlcUA) content, and hyaluronan synthase (HAS) mRNA levels. The maximal inhibition in hyaluronan synthesis ranged 22-80% in the cell lines tested. Active glucuronidation of 4-MU produced large quantities of 4-MU-glucuronide, depleting the cellular UDP-GlcUA pool. The maximal reduction varied between 38 and 95%. 4-MU also downregulated HAS mRNA levels: HAS3 was 84-60% lower in MDA-MB-361, A2058 and SKOV-3 cells. HAS2 was the major isoenzyme in MCF-7 cells and lowered by 81%, similar to 88% in A2058 cells. These data indicate that both HAS substrate and HAS2 and/or HAS3 mRNA are targeted by 4-MU. Despite different target point sensitivities, the reduction of hyaluronan caused by 4-MU was associated with a significant inhibition of cell migration, proliferation and invasion, supporting the importance of hyaluronan synthesis in cancer, and the therapeutic potential of hyaluronan synthesis inhibition.
Authors:
Anne Kultti; Sanna Pasonen-Seppänen; Marjo Jauhiainen; Kirsi J Rilla; Riikka Kärnä; Emma Pyöriä; Raija H Tammi; Markku I Tammi
Related Documents :
11304726 - Antitumor effect of an her2-specific antibody-toxin fusion protein on human prostate ca...
9653056 - In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxi...
12160576 - Are neuroendocrine cells responsible for the development of benign prostatic hyperplasia?
20133806 - Basal epithelial stem cells are efficient targets for prostate cancer initiation.
24150426 - Effect of the successive steps of a cryopreservation protocol on the structural integri...
7686776 - Simultaneous assessment of migration and proliferation of murine fibrosarcoma cells, as...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-03-13
Journal Detail:
Title:  Experimental cell research     Volume:  315     ISSN:  1090-2422     ISO Abbreviation:  Exp. Cell Res.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-01     Completed Date:  2009-06-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0373226     Medline TA:  Exp Cell Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1914-23     Citation Subset:  IM    
Affiliation:
Institute of Biomedicine, Anatomy, University of Kuopio, P.O.B. 1627, FIN-70211 Kuopio, Finland. anne.kultti@uku.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Base Sequence
Breast Neoplasms / drug therapy,  genetics,  metabolism
Cell Line, Tumor
Cell Movement / drug effects
Cell Proliferation / drug effects
DNA Primers / genetics
Down-Regulation / drug effects
Female
Glucuronosyltransferase / genetics,  metabolism*
Humans
Hyaluronic Acid / biosynthesis*
Hymecromone / analogs & derivatives*,  pharmacology
Melanoma / drug therapy,  genetics,  metabolism
Neoplasm Invasiveness / prevention & control
Neoplasms / drug therapy*,  genetics,  metabolism*
RNA, Messenger / genetics,  metabolism
RNA, Neoplasm / genetics,  metabolism
Uridine Diphosphate Glucuronic Acid / metabolism*
Chemical
Reg. No./Substance:
0/4-methylumbelliferone; 0/DNA Primers; 0/RNA, Messenger; 0/RNA, Neoplasm; 2616-64-0/Uridine Diphosphate Glucuronic Acid; 90-33-5/Hymecromone; 9004-61-9/Hyaluronic Acid; EC 2.4.1.-/HAS2 protein, human; EC 2.4.1.-/HAS3 protein, human; EC 2.4.1.17/Glucuronosyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat live...
Next Document:  The role of the cytoskeleton in the formation of gap junctions by Connexin 30.